Adverse effect of mineralocorticoids and their antag, subs

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of mineralocorticoids or their antagonists, occurring during a follow-up visit after initial treatment. It indicates that the patient is still receiving care for the adverse effect, which was previously identified and treated.

Use this code when a patient presents for ongoing management or monitoring of an adverse effect from mineralocorticoid therapy (e.g., fludrocortisone) or from mineralocorticoid receptor antagonists (e.g., spironolactone, eplerenone). This applies to situations where the initial treatment for the adverse effect has already been provided, and the patient is returning for subsequent care.

• Always sequence this code after the code(s) for the specific adverse effect(s) being treated.
• Ensure documentation clearly states the adverse effect is due to a mineralocorticoid or antagonist and that it's a follow-up encounter.
• Do not use for initial encounters or sequelae of adverse effects.